HM
PRTK

Harvest Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Harvest Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,000
Closed -$179K – 118
2017
Q4 		$179K Sell
10,000
-5,000
-33% -$104K 0.12% 68
2017
Q3 		$377K Buy
+15,000
New +$349K 0.24% 42

Other funds holding PRTK

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harvest Management's PRTK Position: Q1 2018 in Review

Harvest Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q1 2018, closing a stake of 10,000 shares — an estimated $179K sold.

Harvest Management first reported a position in PRTK in Q3 2017 and held it in 2 quarters. The position peaked at $377K in Q3 2017. 114 funds tracked by Wall St. Rank hold PRTK as of Q1 2018.

  • Harvest Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Harvest Management sold 10,000 Paratek Pharmaceuticals, Inc. shares in Q1 2018, an estimated $179K.
  • Harvest Management first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2017 and held it in 2 quarters.
  • Harvest Management's Paratek Pharmaceuticals, Inc. position peaked at $377K in Q3 2017.
  • 114 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q1 2018.

Based on Harvest Management's 13F filing for Q1 2018, filed 2 May 2018.